Highly Sensitive and Novel Point-of-Care System, aQcare Chlamydia TRF Kit for Detecting Chlamydia trachomatis by Using Europium (Eu) (III) Chelated Nanoparticles
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The bacterium Chlamydia trachomatis is one of the leading causes of sexually transmitted diseases worldwide. Since no simple and effective tool exists to diagnose C. trachomatis infections, we evaluated a novel point-of-care (POC) test, aQcare Chlamydia TRF kit, which uses europium-chelated nanoparticles and a time-resolved fluorescence reader. Methods: The test performance was evaluated by comparing the results obtained using the novel POC testing kit with those obtained using a nucleic acid amplification test (NAAT), using 114 NAAT-positive and 327 NAAT-negative samples. Results: The cut-off value of the novel test was 20.8 with a detection limit of 0.27 ng/mL. No interference or cross-reactivity was observed. Diagnostic accuracy showed an overall sensitivity of 93.0% (106/114), specificity of 96.3% (315/327), positive predictive value (PPV) of 89.8% (106/118), and negative predictive value (NPV) of 97.5% (315/323). The sensitivity of the novel test was much higher than that of currently available POC tests. Furthermore, the relative ease and short turnaround time (30 min) of this assay enables C. trachomatis-infected individuals to be treated without a diagnostic delay. Conclusions: This simple and novel test is a potential tool to screen a larger population, especially those in areas with limited resources.
Abstract
Background: The bacterium Chlamydia trachomatis is one of the leading causes of sexually transmitted diseases worldwide. Since no simple and effective tool exists to diagnose C. trachomatis infections, we evaluated a novel point-of-care (POC) test, aQcare Chlamydia TRF kit, which uses europium-chelated nanoparticles and a time-resolved fluorescence reader. Methods: The test performance was evaluated by comparing the results obtained using the novel POC testing kit with those obtained using a nucleic acid amplification test (NAAT), using 114 NAAT-positive and 327 NAAT-negative samples. Results: The cut-off value of the novel test was 20.8 with a detection limit of 0.27 ng/mL. No interference or cross-reactivity was observed. Diagnostic accuracy showed an overall sensitivity of 93.0% (106/114), specificity of 96.3% (315/327), positive predictive value (PPV) of 89.8% (106/118), and negative predictive value (NPV) of 97.5% (315/323). The sensitivity of the novel test was much higher than that of currently available POC tests. Furthermore, the relative ease and short turnaround time (30 min) of this assay enables C. trachomatis-infected individuals to be treated without a diagnostic delay. Conclusions: This simple and novel test is a potential tool to screen a larger population, especially those in areas with limited resources.
참고문헌 (26)
- 이임순, "특집", 성매개 질환 발생에 관한 시대적 변천과 현황, 2008, pp.51(10), 868~874[DOI]
- Watson EJ, "The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review", J Med Microbiol, 51, pp.1021~1031 (2002)
- Torrone EA, "Chlamydia trachomatis infection among women 26 to 39 yr of age in the United States, 1999 to 2010", Sex Transm Dis, 40, pp.335~337 (2013)
- Korenromp EL, "What proportion of episodes of gonorrhoea and Chlamydia becomes symptomatic?", Int J STD AIDS, 13, pp.91~101 (2002)
- Patel AL, "Prevalence of Chlamydia infection among women visiting a gynaecology outpatient department: evaluation of an in-house PCR assay for detection of Chlamydia trachomatis", Ann Clin Microbiol Antimicrob, 9, pp.24~ (2010)
- Hajikhani B, "Classical and molecular methods for evaluation of Chlamydia trachomatis infection in women with tubal factor infertility", J Reprod Infertil, 14, pp.29~33 (2013)
- Sachdeva P, "Comparison of an in-house PCR assay, direct fluorescence assay and the Roche AMPLICOR Chlamydia trachomatis kit for detection of C. trachomatis", J Med Microbiol, 58, pp.867~873 (2009)
- Saison F, "Prevalence of Chlamydia trachomatis infection among low- and high-risk Filipino women and performance of Chlamydia rapid tests in resource-limited settings", J Clin Microbiol, 45, pp.4011~4017 (2007)
- Michel CE, "Pitfalls of internet-accessible diagnostic tests: inadequate performance of a CE-marked Chlamydia test for home use", Sex Transm Infect, 85, pp.187~189 (2009)
- Moi H, "Handilab C Chlamydia for home testing is not what it claims", Tidsskr Nor Laegeforen, 127, pp.2083~2085 (2007)
- van Dommelen L, "Alarmingly poor performance in Chlamydia trachomatis point-of-care testing", Sex Transm Infect, 86, pp.355~359 (2010)
- von Lode P, "A europium chelate for quantitative point-of-care immunoassays using direct surface measurement", Anal Chem, 75, pp.3193~3201 (2003)
- Wang Q, "Stable and highly fluorescent europium (III) chelates for time-resolved immunoassays", Inorg Chem, 52, pp.8461~8466 (2013)
- Xia X, "A highly sensitive europium nanoparticle-based lateral flow immunoassay for detection of chloramphenicol residue", Anal Bioanal Chem, 405, pp.7541~7544 (2013)
- Xia X, "Lateral flow immunoassay using europium chelate–loaded silica nanoparticles as labels", Clin Chem, 55, pp.179~182 (2009)
- CLSI, "User protocol for evaluation of qualitative test performance; approved guideline-second edition. CLSI document EP12-2A", Clinical and Laboratory Standards Institute, ~ (2008)
- CLSI, "Protocols for determination of limits of detection and limits of quantitation; approved guideline-second edition. CLSI document EP17", Clinical and Laboratory Standards Institute, ~ (2004)
- CLSI, "Interference testing in clinical chemistry; approved guideline-second edition. CLSI document EP07-A2", Clinical and Laboratory Standards Institute, ~ (2005)
- Juntunen E, "Performance of fluorescent europium (III) nanoparticles and colloidal gold reporters in lateral flow bioaffinity assay", Anal Biochem, 428, pp.31~38 (2012)
- Zhou Y, "Application of europium (III) chelates-bonded silica nanoparticle in time-resolved immunofluorometric detection assay for human thyroid stimulating hormone", Anal Chim Acta, 722, pp.95~99 (2012)
- Järvenpää ML, "Rapid and sensitive cardiac troponin I immunoassay based on fluorescent europium (III)-chelate-dyed nanoparticles", Clin Chim Acta, 414, pp.70~75 (2012)
- van der Helm JJ, "Point-of-care test for detection of urogenital Chlamydia in women shows low sensitivity. A performance evaluation study in two clinics in Suriname", PLoS One, 7, pp.e32122~ (2012)
- Knox J, "Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas", Sex Transm Dis, 29, pp.647~654 (2002)
- Huang W, "Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting", Sex Transm Infect, 89, pp.108~114 (2013)
- Mahilum-Tapay L, "New point of care Chlamydia Rapid Test--bridging the gap between diagnosis and treatment: performance evaluation study", BMJ, 335, pp.1190~1194 (2007)
- Nadala EC, "Performance evaluation of a new rapid urine test for Chlamydia in men: prospective cohort study", BMJ, 339, pp.b2655~ (2009)